Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A peripherally implanted permanent central venous access device.

P Morris1, R Buller, S Kendall

  • 1Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City.

Obstetrics and Gynecology
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Counselling for alcohol problems in primary care in Forth Valley--an innovative approach?

Health bulletin·2003
Same author

Responsiveness of the Problem Areas In Diabetes (PAID) questionnaire.

Diabetic medicine : a journal of the British Diabetic Association·2003
Same author

Vagus nerve stimulation therapy: a research update.

Neurology·2002
Same author

Funding cuts compromise sexual health care.

Nursing New Zealand (Wellington, N.Z. : 1995)·2002
Same author

Nursing service adapts to changing needs and funding.

Nursing New Zealand (Wellington, N.Z. : 1995)·2002
Same author

The public perceptions of the rewards and risks of genetic research: the Oregon story.

Professional ethics report : newsletter of the American Association for the Advancement of Science, Committee on Scientific Freedom & Responsibility, Professional Society Ethics Group·2002
Same journal

The Political Determinants of Obstetric Prescribing.

Obstetrics and gynecology·2026
Same journal

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis.

Obstetrics and gynecology·2026
Same journal

Milestones in Motion: Vaginal Birth After Cesarean.

Obstetrics and gynecology·2026
Same journal

Ebola Virus in Pregnancy.

Obstetrics and gynecology·2026
Same journal

A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

Obstetrics and gynecology·2026
Same journal

The Effects of Climate Change on Obstetric and Gynecologic Health.

Obstetrics and gynecology·2026
See all related articles

A new peripherally accessed totally implantable central venous port offers a safe and effective method for repeated chemotherapy delivery. This innovative device simplifies placement and demonstrates excellent functionality and patient acceptance.

Area of Science:

  • Oncology
  • Vascular Surgery
  • Medical Devices

Background:

  • Totally implanted central venous access devices are crucial for repetitive chemotherapy.
  • Port placement traditionally requires specialized expertise and facilities, posing risks.
  • A need exists for less invasive and more accessible central venous port placement techniques.

Purpose of the Study:

  • To describe the technique and evaluate the efficacy of a new peripherally accessed, totally implantable central venous port.
  • To assess the safety and functionality of this novel port for systemic chemotherapy administration.
  • To gauge patient, nurse, and physician acceptance of the new device.

Main Methods:

  • A novel peripherally accessed, totally implantable central venous port was placed in 22 patients.

Related Experiment Videos

  • Procedures were performed under local anesthesia.
  • Catheter tip placement was confirmed using an electronic sensor wand.

    • Main Results:

    • All 22 ports were successfully placed.
    • The ports were utilized for a cumulative 387 patient-weeks.
    • Twenty-one ports remained functional through 99 chemotherapy courses, with one removal due to infection.
    • Excellent acceptance was reported by patients, nurses, and physicians.

    Conclusions:

    • The peripherally accessed, totally implantable central venous port is a safe and effective option for repeated systemic chemotherapy.
    • This technique simplifies port placement, potentially reducing complications and increasing accessibility.
    • The device demonstrates high functionality and excellent user acceptance in clinical practice.